Progresses of sodium glucose co-transporter-2 inhibitors on improving insulin sensitivity and islet β cell ;function / 中国糖尿病杂志

ABSTRACT

[Summary] Sodium glucose cotransporter 2 (SGLT2) inhibitors have been developed as a new antidiabetic agent .The antihyperglycemic effect of SGLT 2 inhibitors is independent of insulin secretion and insulin action .SGLT2 inhibitors improve IS and islet βcell function with the possible mechanisms of reducing glucotoxicity ,weight loss and increasing GLP‐1 response .